Search or choose
Find the right test or package.
c-kit AML
PCR testing for KIT mutations provides diagnostic, prognostic, and predictive information for systemic mastocytosis (SM), gastrointestinal stromal tumors (GIST), melanoma, and acute myeloid leukemia (AML). Usually, the presence of a KIT mutation in exon 11 is...
DiagnosticsLab test
Know more about this test
PCR testing for KIT mutations provides diagnostic, prognostic, and predictive information for systemic mastocytosis (SM), gastrointestinal stromal tumors (GIST), melanoma, and acute myeloid leukemia (AML). Usually, the presence of a KIT mutation in e...
Understanding c-kit AML
PCR testing for KIT mutations provides diagnostic, prognostic, and predictive information for systemic mastocytosis (SM), gastrointestinal stromal tumors (GIST), melanoma, and acute myeloid leukemia (AML). Usually, the presence of a KIT mutation in exon 11 is associated with a more favorable prognosis and a greater likelihood of response to Imatinib therapy in patients with advanced GIST. The presence of a KIT mutation in exon 9 predicts a less likelihood of response and an increased dose should be considered.
What does c-kit AML measure?
PCR testing for KIT mutations provides diagnostic, prognostic, and predictive information for systemic mastocytosis (SM), gastrointestinal stromal tumors (GIST), melanoma, and acute myeloid leukemia (AML). Usually, the presence of a KIT mutation in exon 11 is associated with a more favorable prognosis and a greater likelihood of response to Imatinib therapy in patients with advanced GIST. The presence of a KIT mutation in exon 9 predicts a less likelihood of response and an increased dose should be considered.
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.